| Symbol | DYN |
|---|---|
| Name | DYNE THERAPEUTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1560 TRAPELO ROAD, WALTHAM, Massachusetts, 02451, United States |
| Telephone | +1 781 786-8230 |
| Fax | — |
| — | |
| Website | https://www.dyne-tx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001818794 |
| Description | Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Additional info from NASDAQ: |
Rhodes Jason P 🔴 sold 106.7K shares of Dyne Therapeutics, Inc. (DYN) at $18.18 ($1.9M) Transaction Date: May 04, 2026 | Filing ID: 000008
Read more📋 Atlas Venture Fund XI, LP (Shareholder) plans to sell 44K shares of Dyne Therapeutics, Inc. (at $17.47 each, total $762K) Filed: May 06, 2026 | ID: 031384
Read more📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 22K shares of Dyne Therapeutics, Inc. (at $17.47 each, total $383K) Filed: May 06, 2026 | ID: 031383
Read more📋 Atlas Venture Associates XI, LP (Shareholder) plans to sell 428 shares of Dyne Therapeutics, Inc. (at $17.47 each, total $7K) Filed: May 06, 2026 | ID: 031382
Read more📋 Atlas Venture Opportunity Fund I, LP (Shareholder) plans to sell 17K shares of Dyne Therapeutics, Inc. (at $17.47 each, total $301K) Filed: May 06, 2026 | ID: 031380
Read more📋 Atlas Venture Fund XI, LP (Shareholder) plans to sell 6K shares of Dyne Therapeutics, Inc. (at $17.71 each, total $108K) Filed: May 05, 2026 | ID: 030665
Read more📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 3K shares of Dyne Therapeutics, Inc. (at $17.71 each, total $54K) Filed: May 05, 2026 | ID: 030662
Read more📋 Atlas Venture Associates XI, LP (Shareholder) plans to sell 60 shares of Dyne Therapeutics, Inc. (at $17.71 each, total $1K) Filed: May 05, 2026 | ID: 030660
Read more📋 Atlas Venture Opportunity Fund I, LP (Shareholder) plans to sell 2K shares of Dyne Therapeutics, Inc. (at $17.71 each, total $43K) Filed: May 05, 2026 | ID: 030659
Read more📋 Atlas Venture Opportunity Fund I, LP (Shareholder) plans to sell 2K shares of Dyne Therapeutics, Inc. (at $17.39 each, total $43K) Filed: May 04, 2026 | ID: 029910
Read more